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ABSTRACT
Twenty-seven S. agalactiae isolates obtained after screening 89 cows for subclinical mastitis were studied 
for antibiotic resistance and virulence genes. The highest resistance was found by Disc diffusion method for 
Streptomycin (85.1%) whereas the lowest resistance was found for Gentamicin (3.7%). Resistance against 
Tetracycline, Erythromycin, Co-trimoxazole, Ampicillin and Enrofl oxacin was 55.5%, 33.3%, 11.1%, 11.1%, 
and 7.4% respectively. PCR based detection revealed three isolates carrying the tetO gene associated with 
Tetracycline resistance and seven isolates carrying the ErmB gene associated with Erythromycin resistance. 
Molecular detection of virulence associated genes revealed that out of 27 isolates of S. agalactiae, none 
was carrying the bca gene, while 6, 7, 8 and 6 isolates were positive for ScpB, rib, lmb and cylE genes 
respectively.
Key words: chronic, contagious, disc diffusion, mastitis, molecular detection, resistance, virulence________________________________________________________________________________________
Introduction
S. agalactiae, the lone member of the Lancefi eld group B, is an important cause of 
chronic, contagious bovine mastitis. It also causes mastitis and invasive disease in camels 
and is an occasional cause of disease in dogs, cats, fi sh, and hamsters. Its presence is 
frequently associated with high somatic cell counts in milk and decreased milk yield. 
Unidentifi ed carrier cows are responsible for spreading the pathogen to herdmates (KEEFE, 
1997). S. agalactiae infections have major consequences for public health, because they 
may cause neurological problems in newborn humans and endometritis and sterility in 
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the mothers. The major component of the Streptococcal cell surface is a polysaccharide 
coat, which is serotype specifi c. A complement of proteins is embedded throughout this 
coat. To date, only a few such proteins have been identifi ed. Predominant amongst these 
are the tandem repeat proteins, including Cα protein (WILKINSON and EAGON, 1971), R 
protein (LANCEFIELD and PERLMANN, 1952), Rib protein (WÄSTFELT et al., 1996), the 
Cβ protein (RUSSELL et al., 1992) and X protein (RAINARD et al., 1991). Other identifi ed 
outer surface proteins include glutamine synthetase (SUVOROV et al., 1997) and α enolase 
(PANCHOLI and FISCHETTI, 1998). 
The severity of neonatal disease in Group B streptococcus (GBS) infections may be 
determined mostly by the number of virulence factors encoded, among others by the cps 
gene cluster coding for the capsule and the scpB gene coding for surface enzyme ScpB (a 
C5a peptidase), which causes impairing of neutrophil recruitment and binds fi bronectin 
to promote bacterial invasion of epithelial cells (BECKMANN et al., 2002). Previously, 
C5a peptidase genes were found only in group B streptococci (scpB gene), group A 
streptococci (scpA gene) and group G streptococci (scpG gene) (FRANKEN et al., 2001). 
The ScpB gene, being extremely homologous to the scpA and scpG genes, has a 51 bp 
deletion at the 3’-end of the gene (CHMOURYGUINA et al., 1996). The bca gene codes for 
alpha-C protein, a surface protein that helps the bacteria to enter the host cells (BOLDUC 
et al., 2002), the lmb gene codes for lmb (laminine-binding protein), a surface protein that 
plays a role in the invasion of the damaged epithelium (SPELLERBERG et al., 1999), the 
cylE gene codes for β-hemolysin, a toxin that plays a role in tissue injury and the systemic 
spread of the bacteria and contributes to meningitis (DORAN et al., 2003), and the rib 
gene encodes the surface Rib protein mostly present in invasive strains (STALHAMMAR 
et al., 1993). The CAMP factor is a 23.5 kDa ceramide binding protein of S. agalactiae 
that potentiates the action of staphylococcal sphingomyelinase (beta toxin). The lethal 
properties of the CAMP factor for cell cultures and for rabbits and mice suggest that it 
may have a cytotoxic action for mammary tissue. S. agalactiae is an obligate parasite of 
the epithelium and tissues of ruminant mammary glands, and eradication of the organism 
from herds is, therefore, possible by identifi cation of animals with mammary infection 
followed by treatment or culling. 
Treatment with intramammary infusion of antibiotics is the main approach to deal 
with the infection, and a number of studies on in vivo and in vitro trials to assess the 
antibiotic sensitivity/resistant pattern have been documented. However, there are few 
reports focusing upon the genes involved in resistance especially for S. agalactiae isolates 
of bovine origin. GBS resistant to penicillin has not been reported so far. However, rare 
GBS clinical strains with reduced sensitivity for penicillin have been recorded. The 
present study aims to identify antibiotic resistant and virulence genes in Streptococcus 
agalactiae isolated from subclinical mastitis cases. 
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Materials and methods 
The present study focused on the isolation and identifi cation of the S. agalactiae, 
antibiotic sensitivity pattern of S. agalactiae isolates, PCR based detection of S. agalactiae 
and genes associated with virulence and antibiotic resistance. All the 27 isolates were 
from cattle. The antibiotic discs were obtained from HiMedia Laboratories Ltd. Mumbai. 
Isolates were tested against commonly used antibiotics viz: Streptomycin, Tetracycline, 
Co-Trimoxazole, Enrofl oxacin, Erythromycin, Gentamicin and Ampicillin. All the 
confi rmed S. agalactiae isolates were subjected to an antibiotic sensitivity test by the 
Disc diffusion method using MH media.







Diameter of zone of  inhibition (mm)*
R I S
1 Streptomycin ST 300 mcg 11 12-14 15
2 Tetracycline T 10 mcg 14 15-18 19
3 Ampicillin A 10 mcg 18 19-21 22
4 Enrofl oxacin En 10 mcg 15 16-20 21
5 Cotrimoxazole CO 25 mcg 15 16-20 21
6 Erythromycin E 15 mcg 12 13-16 17
7 Gentamicin G 10 mcg 12 13-14 15
R - Resistant; I - Intermediate; S - Sensitive
PCR was carried out to identify the isolates by using primer sagF 432 and sagR1086 
as per RIFFON et al. (2001). For detection of antibiotic resistance genes from the confi rmed 
S. agalactiae isolates, PCR was carried out using primer pairs as per DOGAN et al. (2005) 
(Table 2).
Table 2. Details of primers used for antibiotic resistance genes









The initial denaturation temperature was 94 °C for 5 min. Denaturation was done for 
30 sec. for the ErmB gene and 1 min. for the tetO gene. Annealing was done at 50 °C for 
the ErmB gene and at 55 °C for the tetO gene for 30 sec. and 1 min. respectively. Extension 
was done for 1 min. and 1 min. 30 sec. for the ErmB and tetO genes respectively.
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PCR was carried out for the virulence associated genes using primers as given in 
Table 3.
Table 3. Primers used for the virulence associated genes were as follows


































BERGSENG et al. 
(2007)
Initial denaturation was done at 94 °C for the scpB gene (1 min.) and at 95 °C for 
the rib, bca, CylE and lmb genes for 5 min., 5 min., 10 min. and 5 min. respectively. 
Denaturation was done at 94 °C for 1 min. Annealing of the ScpB gene was done at 47 °C 
for 1 min., the rib gene at 55 °C for 30 sec., the bca gene at 55 °C for 30 sec., the CylE 
gene at 55 °C for 1 min. and for the lmb gene at 54 °C for 1 min. Extension was done at 
72 °C for 2 min. Total cycles were kept 35.
Results
 All the 27 isolates of S. agalactiae were tested for in vitro sensitivity to seven 
antibacterial drugs and the sensitivity/resistance of individual isolates to various drugs 
was interpreted according to the manufacturer’s instructions (Hi Media Ltd., Mumbai, 
India). In the present study, S. agalactiae isolates were found variably resistant to 
the antibiotics tested. Overall, the highest percentage of the isolates were resistant to 
Streptomycin (85.1%), followed by Tetracycline (55.5%), Erythromycin (33.3%), Co-
trimoxazole (11.1%), Ampicillin (11.1%), Enrofl oxacin (7.4%) and  Gentamicin (3.7%). 
Out of 27 isolates tested for identifi cation of Tetracycline resistance genes, three 
isolates could be identifi ed as Tetracycline resistant as they yielded an amplifi cation 
product of 1723 bp and seven isolates could be identifi ed as Erythromycin resistant as 
they yielded an amplifi cation product of 442 bp (Fig. 1).
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Fig. 1 (a) and (b): Agarose gel electrophoresis of PCR amplifi ed Tetracycline and Erythromycin 
resistant genes, product showing 1723 bp using primer set tet(O) and 442 bp using primer set 
ErmB respectively
Molecular detection of virulence associated genes in 27 S. agalactiae isolates revealed 
that none of the isolate was carrying the bca gene. Six isolates were positive for the ScpB 
gene, seven isolates for the rib gene, eight isolates for the lmb gene and six isolates were 
positive for the cylE gene (Fig. 2).
Fig. 2 (a), (b), (c) and (d): Agarose gel electrophoresis of PCR amplifi ed ScpB gene, rib gene, lmb 
gene and cylE genes showing product size 255bp, 369bp, 572bp, 248bp respectively
(a)                         (b)
(c)                    (d)
(a)                  (b)
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Discussion 
S. agalactiae infections in both humans and bovines are treated by administration 
of antibiotics. Penicillin is the drug of choice for treatment of both human and bovine 
S. agalactiae infections (SCHRAG et al., 2000). For penicillin-allergic individuals, 
erythromycin and clindamycin are recommended. The prevalence of resistance to 
erythromycin and clindamycin has been increasing in S. agalactiae (UH et al., 2001); 
recently, resistance to erythromycin has been associated with human S. agalactiae 
serotype III and V isolates (LIN et al., 2000). Extensive use of antibiotics in medicine and 
animal husbandry results in increased antibiotic resistance among bacterial populations. 
Several studies have suggested that antimicrobial use in animals causes the development 
of antibiotic resistance among pathogens in humans.
In the present study 15 out of 27 isolates were resistant to Tetracycline based on the disc 
diffusion method, whereas four isolates were found sensitive. Out of 15 resistant isolates, 
only two isolates were found positive for Tetracycline resistance gene (tetO) and thirteen 
isolates were negative. All the four Tetracycline sensitive isolates were also negative for 
the presence of the Tetracycline resistance gene (Table 4).   




R S I Total
+ve 2 0 1 3
-ve 13 4 7 24
Total 15 4 8 27
R- Resistant, S- Sensitive, I-Intermediate
Out of nine Erythromycin resistant isolates shown by the disc diffusion method, two 
isolates had the gene associated with the Erythromycin resistance. A total of fi ve isolates 
had the Erythromycin resistance gene of 18 Erythromycin sensitive isolates, whereas the 
remaining 13 isolates were negative for the presence of the Erythromycin resistance gene 
(Table 5).




R S I Total
+ve 2 5 0 7
-ve 7 13 0 20
Total 9 18 0 27
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Out of 27 isolates of S. agalactiae, none of the isolates carried the bca gene as evident 
from the absence of the 183 bp PCR product. HANNOUN et al. (2009) observed 56.5% 
isolates positive for the bca gene. In the present study the ScpB gene was found in 22.2% 
(6/27) isolates. According to DMITRIEV et al. (2004), all the strains isolated from humans 
and only 9% of bovine isolates had the ScpB gene. DMITRIEV et al. (2004) observed that 
the presence of the ScpB gene is more frequent in bovine isolates. The majority of S. 
agalactiae strains express one or more surface-anchored proteins, such as the Rib protein, 
that vary by strains. These proteins are characteristic for S. agalactiae, and are able to 
induce the formation of protective antibodies. In the present study, 25.9% (7/27) isolates 
were found positive for the presence of the rib gene. MAELAND et al. (2005) observed 
93% (56/60) and VIDOVA et al. (2009) 73% isolates positive for the presence of the rib 
gene. Adherence to extracellular matrix proteins is considered an important factor in the 
pathogenesis of Streptococcal infection. The lmb gene (laminin binding protein) plays 
an important role in the adherence of S. agalactiae. 29.6% (8/27) isolates were found to 
contain the lmb gene in the present study. According to SPELLERBERG et al. (1999), the 
lmb gene was present in the common serotypes of S. agalactiae. The cylE genes of S. 
agalactiae are required for the production of hemolysin and in the present study, 22.2% 
(6/27) isolates had the cylE gene. SPELLERBERG et al. (2000) observed 23% isolates 
positive for the cylE gene, while BERGSENG et al. (2007) found 34.3% positivity. 
The study resulted in obtaining the S. agalactiae isolates, which were identifi ed and 
characterized by conventional as well as molecular approaches. The real output was 
regarding the antibiotic resistance profi le, especially the PCR based detection of genes 
associated with resistance and also the molecular detection of a few important genes 
associated with virulence of S. agalactiae. More elaborate studies are recommended, 
including a much larger sample of subclinical mastitis cases and S. agalactiae isolates, 
as well as targeting more genes associated with antibiotic resistance and virulence, to 
understand the mechanism that plays a role at the genetic level so as to understand further 
the pathobiology of S. agalactiae and the menace of subclinical mastitis. 
In conclusion it may be logically inferred that there was no defi nite pattern observed 
in antibiotic resistance by the phenotypic and genotypic methods. As with Tetracycline, 
two of the three S. agalactiae isolates found to be Tetracycline resistant genotypically, 
were also observed as Tetracycline resistant phenotypically, but the other S. agalactiae 
isolates, which were Tetracycline resistant phenotypically, were not found to contain a 
gene associated with resistance to Tetracycline. In the case of Erythromycin, fi ve of the 
S. agalactiae isolates which were positive for the presence of a gene associated with 
resistance, were observed to be sensitive to Erythromycin by the Disc diffusion method 
and a few phenotypically resistant isolates were found to be negative for the presence 
of a gene associated with resistance to Erythromycin. This is possible as there are other 
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factors playing a role in conferring resistance, including the role of other genes such 
as: tet(M), tet(S), tet(W), tet(Q) and tet(B) for Tetracycline and erm(A) and mef(A) for 
Erythromycin.
References
BECKMANN, C., J. D. WAGGONER, T. O. HARRIS, G. S. TAMURA, C. E. RUBENS (2002): 
Identifi cation of novel adhesins from Group B streptococci by use of phage display reveals that 
c5a peptidase mediates fi bronectin binding. Infect. Immun. 70, 2869-2876.
BERGSENG, H., L. BEVANGER, M. RYGG, K. BERGH (2007): Real-time PCR targeting the 
sip gene for detection of group B streptococcus colonization in pregnant women at delivery. J. 
Med. Microbiol. 56, 223-228. 
BOLDUC, G. R., M. J. BARON, C. GRAVEKAMP, C. S. LACHENAUER, L. C. MADOFF 
(2002): The alpha C protein mediates internalization of group B streptococcus within human 
cervical epithelial cells. Cell. Microbiol. 4, 751-758.
CHMOURYGUINA, I., A. SUVOROV, P. FERRIERI, P. P. CLEARY (1996): Conservation of C5a 
peptidase genes in group A and B streptococci. Infect. Immun. 64, 2387-2390.
DMITRIEV, A., A. SUVOROV, A. SHEN, Y. H. YANG (2004): Clinical diagnosis of group B 
streptococci by scpB gene based PCR. Indian J. Med. Res. 119, 233-236.
DORAN, K. S., G. Y. LIU, V. NIZET (2003): Group B streptococcal beta-hemolysin/cytolysin 
activates neutrophil signaling pathways in brain endothelium and contributes to development 
of meningitis. J. Clin. Invest. 112, 736-744.
DOGAN, B., Y. H. SCHUKKEN, C. SANTISTEBAN, K. J. BOOR (2005): Distribution of 
serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from 
bovine and human host. J. Clin. Microbiol. 43, 5899-5906.
FRANKEN, C., G. HAASE, C. BRANDT, J. WEBER-HEYNEMANN, S. MARTIN, C. LAMMLER, 
A. PODBIELSKI, R. LUTTICKEN, B. SPELLERBERG (2001): Horizontal gene transfer and 
host specifi city of beta-haemolytic streptococci: the role of a putative composite transposon 
containing scpB and lmb. Mol. Microbiol. 41, 925-935.
HANNOUN, A., M. SHEHAB, M.T. KHAIRALLAH, A. SABRA, R. ABI-RACHED, T. BAZI, K. 
A. YUNIS, G. F. ARAJ, G. M. MATAR (2009): Correlation between group B streptococcal 
genotypes, their antimicrobial resistance profi les, and virulence genes among pregnant women 
in Lebanon. Int. J. Microbiol. 01/2009; 2009:796512.
KEEFE, G. P. (1997): Streptococcus agalactiae mastitis: A review. Can. Vet. J. 38, 429-437.
LANCEFIELD, R. C., G. E. PERLMANN (1952): Preparation and properties of a protein (R 
antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other 
serological groups. J. Exp. Med. 96, 83-97.
LIN, F. Y., P. H. AZIMI, L. E. WEISMAN, J. B. PHILIPS, J. REGAN, P. CLARK, G. G. RHOADS, 
J. CLEMENS, J. TROENDLE, E. PRATT, R. A. BRENNER, V. GILL (2000): Antibiotic 
susceptibility profi les for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. 
Dis. 31, 76-79.
431Vet. arhiv 82 (5), 423-432, 2012
B. Jain et al.: Antibiotic resistance and virulence genes in Streptococcus agalactiae 
MAELAND, J. A., L. BEVANGER, R.V. LYNG (2005): Immunological markers of the R4 protein 
of Streptococcus agalactiae. Clin. Diagn. Lab. Immunol. 12, 1305-1310.
MANNING, S. D., M. KI, C. F. MARRS, K. J. KUGELER, S. M. BORCHARDT, C. J. BAKER, 
B. FOXMAN (2006): The frequency of genes encoding three putative group B streptococcal 
virulence factors among invasive and colonizing isolates. BMC Infect. Dis. doi:10.1186/1471-
2334-6-116
PANCHOLI, V., V. A. FISCHETTI (1998): Alpha-enolase, a novel strong plasmin(ogen) binding 
protein on the surface of pathogenic streptococci. J. Biol. Chem. 273, 14503-14515.
RAINARD, P., Y. LAUTROU, P. SARRADIN, B. POUTREL (1991): Protein X of Streptococcus 
agalactiae induces opsonic antibodies in cows. J. Clin. Microbiol. 29, 1842-1846.
RIFFON, R., K. SAYASITH, H. KHALIL, P. DUBREUIL, M. DROLET, J. LAGACE (2001): 
Development of a rapid and sensitive test for identifi cation of major pathogens in bovine 
mastitis by PCR. J. Clin. Microbiol. 39, 2584-2589.
RUSSELL, R. B., J. BREED, G. J. BARTON (1992): Conservation analysis and secondary structure 
prediction of the sh2 family of phosphotyrosine binding domains. FEBS Lett. 304, 15-20.
SCHRAG, S. J., S. ZYWICKI, M. M. FARLEY, A. L. REINGOLD, L. H. HARRISON, L. B. 
LEFKOWITZ, J. L. HADLER, R. DANILA, P. R. CIESLAK, A. SCHUCHAT (2000): Group 
B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342, 
15-20.
SPELLERBERG, B., E. ROZDZINSKI, S. MARTIN, J. WEBER-HEYNEMANN, N 
SCHNITZLER, R. LUTTICKEN, A. PODBIELSKI (1999): Lmb, a Protein with Similarities 
to the LraI Adhesin Family, Mediates Attachment of Streptococcus agalactiae to Human 
Laminin. Infect. Immun. 67, 871-878.
SPELLERBERG, B., S. MARTIN, C. BRANDT, R. LUTTICKEN  (2000): The cyl genes of 
Streptococcus agalactiae are involved in the production of pigment. FEMS Microbiol Lett. 188, 
125-128.
STALHAMMAR-CARLEMALM, M., L. STENBERG, G. LINDAHL (1993): Protein Rib: a novel 
group B streptococcal cell surface protein that confers protective immunity and is expressed by 
most strains causing invasive infections. J. Exp. Med. 177, 1593-1603.
SUVOROV, A., A. DMITRIEV, I. USTINOVITCH, C. SCHALEN, A.A. TOTOLIAN (1997): 
Molecular analysis of clinical group B streptococcal strains by use of alpha and beta gene 
probes. FEMS Immunol. Med. Microbiol. 17, 149 -154.
UH, Y., I. H. JANG, G. Y. HWANG, K. J. YOON, W. SONG (2001). Emerging erythromycin 
resistance among group B streptococci in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 20, 52-54.
VIDOVA, B., M. CHOTAR, J. TIMKO, A. GODANY (2009): Multiplex PCR method for detection 
of variability in genes encoding the alpha Streptococcus agalactiae. Nova Biotechnologica 9, 
63-70.
WÄSTFELT, M., M. STALHAMMAR-CARLEMALM, A. M. DELISSE, T. CABEZON, G. 
LINDAHL (1996): Identifi cation of a family of streptococcal surface proteins with extremely 
repetitive structure. J. Biol. Chem. 271, 18892-18897.
432 Vet. arhiv 82 (5), 423-432, 2012
B. Jain et al.: Antibiotic resistance and virulence genes in Streptococcus agalactiae 
WILKINSON, H. W., R. G. EAGON (1971): Type-specifi c antigens of group B type Ic streptococci. 
Infect. Immun. 4, 596-604.
Received: 28 September 2011
Accepted: 17 April 2012
________________________________________________________________________________________
JAIN, B., A. TEWARI, B. B. BHANDARI, M. K. JHALA: Otpornost na antibiotike 
i geni za virulenciju sojeva vrste Streptococcus agalactiae izdvojenih iz krava kod 
supkliničke upale mliječne žlijezde. Vet. arhiv 82, 423-432, 2012.
SAŽETAK
Ukupno je 27 izolata vrste S. agalactiae bilo izdvojeno iz 89 krava sa supkliničkom upalom mliječne žlijezde 
te pretraženo na otpornost na antibiotike i gene za virulenciju. Difuzijskim postupkom ustanovljeno je da su izolati 
najčešće bili otporni na streptomicin (85,1%), a najrjeđe na gentamicin (3,7%). Otpornost na tetraciklin dokazana je 
u 55,5% izolata, na eritromicin u 33,3%, na kotrimoksazol u 11,1%, na ampicilin u 11,1% te na enrofl oksacin u 7,4% 
izolata. Lančanom reakcijom polimerazom u tri je izolata dokazan gen tetO povezan s otpornošću na tetraciklin, a u 
sedam gen ErmB povezan s otpornošću na eritromicin. Molekularnim dokazivanjem gena odgovornih za virulenciju 
ni u jednog od 27 pretraženih izolata vrste S. agalactiae nije bio dokazan gen bca, dok je u šest izolata bio dokazan 
gen ScpB, u sedam gen rib, u osam gen lmb te u šest izolata gen cylE.
Ključne riječi: mastitis, Streptococcus agalactiae, antibiotici, otpornost, virulencija, geni  ________________________________________________________________________________________
